Advertisement

The time bomb of IGT

      Let’s talk numbers: the 8th edition of the Diabetes Atlas 2017 reports that over 350 million people between 20 and 79 years worldwide are estimated to have developed impaired glucose tolerance (IGT). Translated, this estimate equates to more than every 14th person worldwide with impaired glucose regulation after testing for an oral glucose tolerance test (OGTT), routinely used for diagnosing type 2 diabetes. IGT occurs when results are above the normal range (7.8 mmol/L (140.4 mg/dL) to 11.1 mmol/L (199.8 mg/dL)), but not high enough to be classified as having diabetes. IGT, also called prediabetes, carries a high risk for developing type 2 diabetes. Prediabetes is a term that covers varying degrees of altered glucose metabolism.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Andersson S.
        • Ekman I.
        • Lindblad U.
        • et al.
        Perceived symptoms in people living with impaired glucose tolerance.
        Nurs Res Pract. 2011; 2011: 1-9
        • Nathan D.M.
        • Davidson M.B.
        • DeFronzo R.A.
        • et al.
        Impaired fasting glucose and impaired glucose tolerance.
        Diabetes Care. 2007; 30: 753-759
      1. World Health Organization. Global Health Observatory data repository, life table by country (internet). WHO. World Health Organization; 2015 <http://apps.who.int/gho/data/node.main.LIFECOUNTRY?lang=en> [cited 2017 June 6].

        • World Health Organization
        Global tuberculosis report 2016.
        World Health Organization, Geneva (Switzerland)2016
        • Dall T.M.
        • Yang W.
        • Halder P.
        • et al.
        The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes.
        Diabetes Care. 2014; 37: 3172-3179
        • Vazquez G.
        • Duval S.
        • Jacobs Jr, D.R.
        • Silventoinen K.
        Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis.
        Epidemiol Rev. 2007; 29: 115-128
        • Forouzanfar M.H.
        • Alexander L.
        • Anderson H.R.
        • et al.
        Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.
        The Lancet. 2015; 386: 2287-2323
        • Diabetes Prevention Program Research Group
        Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the diabetes prevention program outcomes study.
        Lancet Diab Endocrinol. 2015; 3: 866-875
        • Gilinsky A.S.
        • Kirk A.F.
        • Hughes A.R.
        • et al.
        Lifestyle interventions for type 2 diabetes prevention in women with prior gestational diabetes: a systematic review and meta-analysis of behavioural, anthropometric and metabolic outcomes.
        Prev Med Rep. 2015; 2: 448-461
        • Howells L.
        • Musaddaq B.
        • McKay A.J.
        • Majeed A.
        Clinical impact of lifestyle interventions for the prevention of diabetes: an overview of systematic reviews.
        BMJ Open. 2016; 6: e013806